Suppr超能文献

新型半合成胆汁酸衍生物作为有效的酪氨酰 DNA 磷酸二酯酶 1 抑制剂。

Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors.

机构信息

N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, SB RAS, acad. Lavrentjev ave. 9, Novosibirsk 630090, Russia.

Novosibirsk Institute of Chemical Biology and Fundamental Medicine, SB RAS, acad. Lavrentjev ave. 8, Novosibirsk 630090, Russia.

出版信息

Molecules. 2018 Mar 17;23(3):679. doi: 10.3390/molecules23030679.

Abstract

An Important task in the treatment of oncological and neurodegenerative diseases is the search for new inhibitors of DNA repair system enzymes. Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is one of the DNA repair system enzymes involved in the removal of DNA damages caused by topoisomerase I inhibitors. Thus, reducing the activity of Tdp1 can increase the effectiveness of currently used anticancer drugs. We describe here a new class of semisynthetic small molecule Tdp1 inhibitors based on the bile acid scaffold that were originally identified by virtual screening. The influence of functional groups of bile acids (hydroxy and acetoxy groups in the steroid framework and amide fragment in the side chain) on inhibitory activity was investigated. In vitro studies demonstrate the ability of the semisynthetic derivatives to effectively inhibit Tdp1 with IC up to 0.29 µM. Furthermore, an excellent fit is realized for the ligands when docked into the active site of the Tdp1 enzyme.

摘要

在治疗肿瘤和神经退行性疾病方面,一个重要的任务是寻找新的 DNA 修复系统酶抑制剂。酪氨酸-DNA 磷酸二酯酶 1(Tdp1)是参与修复拓扑异构酶 I 抑制剂引起的 DNA 损伤的 DNA 修复系统酶之一。因此,降低 Tdp1 的活性可以提高目前使用的抗癌药物的疗效。我们在这里描述了一类新的基于胆酸支架的半合成小分子 Tdp1 抑制剂,这些抑制剂最初是通过虚拟筛选发现的。研究了胆酸的官能团(甾体骨架中的羟基和乙酰氧基以及侧链中的酰胺片段)对抑制活性的影响。体外研究表明,半合成衍生物具有有效抑制 Tdp1 的能力,IC 高达 0.29µM。此外,当配体对接进入 Tdp1 酶的活性位点时,实现了极好的拟合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f31/6017735/9b7ea4851608/molecules-23-00679-g001.jpg

相似文献

4
Synthesis and evaluation of aryliden- and hetarylidenfuranone derivatives of usnic acid as highly potent Tdp1 inhibitors.
Bioorg Med Chem. 2018 Aug 15;26(15):4470-4480. doi: 10.1016/j.bmc.2018.07.039. Epub 2018 Jul 24.
5
Identification of novel inhibitors for the tyrosyl-DNA-phosphodiesterase 1 (Tdp1) mutant SCAN1 using virtual screening.
Bioorg Med Chem. 2020 Jan 1;28(1):115234. doi: 10.1016/j.bmc.2019.115234. Epub 2019 Nov 30.
10
Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety.
Bioorg Med Chem. 2015 May 1;23(9):2044-52. doi: 10.1016/j.bmc.2015.03.020. Epub 2015 Mar 12.

引用本文的文献

4
A Dual-Sensor-Based Screening System for In Vitro Selection of TDP1 Inhibitors.
Sensors (Basel). 2021 Jul 15;21(14):4832. doi: 10.3390/s21144832.
5
Validating TDP1 as an Inhibition Target for the Development of Chemosensitizers for Camptothecin-Based Chemotherapy Drugs.
Oncol Ther. 2021 Dec;9(2):541-556. doi: 10.1007/s40487-021-00158-0. Epub 2021 Jun 23.
6
Discovery of Novel Sultone Fused Berberine Derivatives as Promising Tdp1 Inhibitors.
Molecules. 2021 Mar 30;26(7):1945. doi: 10.3390/molecules26071945.
7
Physiology and Physical Chemistry of Bile Acids.
Int J Mol Sci. 2021 Feb 10;22(4):1780. doi: 10.3390/ijms22041780.

本文引用的文献

1
Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors.
Bioorg Chem. 2018 Feb;76:392-399. doi: 10.1016/j.bioorg.2017.12.005. Epub 2017 Dec 9.
2
Tyrosyl-DNA phosphodiesterases: rescuing the genome from the risks of relaxation.
Nucleic Acids Res. 2018 Jan 25;46(2):520-537. doi: 10.1093/nar/gkx1219.
3
PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer.
Clin Pharmacokinet. 2018 Apr;57(4):427-437. doi: 10.1007/s40262-017-0587-4.
7
Tyrosyl-DNA Phosphodiesterase 1 Inhibitors: Usnic Acid Enamines Enhance the Cytotoxic Effect of Camptothecin.
J Nat Prod. 2016 Nov 23;79(11):2961-2967. doi: 10.1021/acs.jnatprod.6b00979. Epub 2016 Nov 14.
8
Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential.
Bioorg Med Chem. 2016 Nov 1;24(21):5017-5027. doi: 10.1016/j.bmc.2016.09.045. Epub 2016 Sep 20.
9
New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties.
Bioorg Med Chem. 2016 Nov 1;24(21):5573-5581. doi: 10.1016/j.bmc.2016.09.016. Epub 2016 Sep 13.
10
Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors.
Clin Cancer Res. 2017 Feb 15;23(4):1001-1011. doi: 10.1158/1078-0432.CCR-16-1193. Epub 2016 Aug 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验